SCHEMBL9115171

SCHEMBL9115171

OC[C@@H]1CCC(n2cnc3c(Cl)ncnc32)S1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 1/20 0.38
▸ FGFR4 P22455 1/20 0.38
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ FDPS P14324 1/20 0.37
▸ AHCY P23526 3/20 0.37
▸ ADORA2B P29275 2/20 0.37
▸ ADORA2A P29274 4/20 0.37
▸ DGAT1 O75907 1/20 0.36
▸ TYMP P19971 1/20 0.36
▸ ADORA1 P30542 3/20 0.36
▸ ADORA3 P0DMS8 2/20 0.36
▸ ADA P00813 1/20 0.36
▸ P2RX7 Q99572 1/20 0.36
▸ PI4KA P42356 1/20 0.35
▸ PI4K2B Q8TCG2 1/20 0.35
▸ PI4K2A Q9BTU6 1/20 0.35
▸ PI4KB Q9UBF8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9115181 1.00 FGFR1 (0.38) FGFR1FGFR4PDE4APDE4BPDE4C
SCHEMBL9114922 0.86 ADORA2A (0.38) AHCYADORA2BADORA2AADORA1ADORA3
SCHEMBL9114924 0.86 ADORA2A (0.38) AHCYADORA2BADORA2AADORA1ADORA3
SCHEMBL9115027 0.85 ADORA2A (0.56) AHCYADORA2BADORA2AADORA1ADORA3
SCHEMBL9115023 0.85 ADORA2A (0.56) AHCYADORA2BADORA2AADORA1ADORA3
SCHEMBL29514954 0.85 ADORA2A (0.56) AHCYADORA2BADORA2AADORA1ADORA3
SCHEMBL12960586 0.81 AHCY (0.41) PDE4DAHCY
SCHEMBL9113289 0.81 YTHDC1 (0.59) AHCYADORA2AADORA1ADORA3
SCHEMBL8469767 0.78 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DFDPS
SCHEMBL8469585 0.78 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DFDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5478928-A Useful as antiviral agents in the treatment and prevention of AIDS SOUTHERN RESEARCH INSTITUTE (US) 1995-12-26 — — US claimed
WO-1995011685-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1995-05-04 — — WO claimed
US-5478928-A Useful as antiviral agents in the treatment and prevention of AIDS SOUTHERN RESEARCH INSTITUTE (US) 1995-12-26 — — US disclosed
WO-1995011685-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1995-05-04 — — WO disclosed
EP-0525106-A4 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS — 1993-04-21 — — EP disclosed
EP-0525106-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1993-02-03 — — EP disclosed
US-5128458-A 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 1992-07-07 — — US disclosed
WO-1991016333-A1 2',3'-DIDEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AGENTS SOUTHERN RESEARCH INSTITUTE (US) 1991-10-31 — — WO disclosed
Send feedback